novavax
Novavax says COVID vaccine triggers immune response to Omicron variant
Novavax said it is working on developing an Omicron-specific vaccine and expects to begin manufacturing its doses in January
WHO experts recommend Novavax vaccine's third dose for people with health issues
On Friday, the WHO issued an emergency use listing to Novavax's vaccine made by the Serum Institute of India
Novavax COVID-19 vaccine could get EU approval next week
The WHO said on Thursday that it would reveal its position over the vaccine in the coming days, following an expert group meeting
Serum Institute plans to launch Novavax shot for children in six months
The Novavax shot has shown good results in trials in children aged three and older, said Adar Poonawalla
Novavax files for emergency use listing of COVID-19 vaccine with WHO
Novavax and its partner SII had said that they had received the first emergency use authorisation for Covid vaccine in Indonesia
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid vaccine trial
Serum Institute is already conducting a trial of its COVID-19 vaccine Covovax
Novavax holds vaccine trials in US, Mexico, says shot 90% effective against Covid
Novavax's study involved nearly 30,000 people aged 18 and up in the US and Mexico
Serum Institute applies for trials of another Covid-19 vaccine
The firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca
Novavax announces COVID-19 vaccine supply deal with Serum Institute
Novavax reported that its experimental vaccine produced high levels of antibodies against coronavirus in a small, early-stage clinical trial